France develops a new vaccine against dengue fever
-
Last Update: 2020-07-06
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
the French Pasteur Institute issued a communiquethe 2nd,,the institute and the French National Research Center researchers recently developed a new vaccine against dengue,and has been successfully tested in animals,researchersthe antigen strain of the dengue I virus into a variant of the measles vaccine,and inject it into mice as a vaccine, and then inject edited the dengue virusThe results showed that the new vaccine canfor a long time,effectively promote the production of antibodies in mice, thereby destroying the dengue virusThe findings have been published in the new issue of the American Journal of Public Library of Science Neglected Tropical DiseasesThe communique said that the measles vaccine is currently recognized as the safest and most effective vaccine in the world, the World Health Organization is promoting the vaccine to countries, if it is used as a direct carrier of dengue vaccine, it is expected to develop a "double-effect vaccine" to prevent both measles and dengue feverAccording to Frederic Tangi, who was involved in the study, there are four types of dengue fever, and the ultimate goal of the researchers is to develop a vaccine that is long-term effective at all, and that it must be cheap enough to make it affordable for all Dengue fever is an acute viral infection transmitted by mosquitoes, mostly in tropical areas, characterized by fever
headaches
, muscle and joint pain throughout the body About 60 to 100 million people worldwide are infected with the disease each year , and there is no effective vaccine to prevent dengue fever Xinhua
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.